Supplementary Figure 1.
were harvested by centrifugation and cells were lysed as described previously 27 . Finally, proteins from cell lysate were extracted with Triton X-100 (1%) and cell debris was separated by centrifugation at 18500 g for 10 min at 4°C. The resultant supernatant was incubated with glutathione-Sepharose beads for 1 h at 4°C. Beads were extensively washed with PBS, recombinant proteins were eluted from the beads in 50 mM Tris-HCl containing 30 mM glutathione, pH 9.0, and dialyzed against PBS. Purity of the proteins was checked by SDS-PAGE.
Our results showed the purification of expected size (75 kDa) of GST-LdGDI to homogeneity (lane 4). Lane1, Protein marker; Lane 2, Uninduced lysate of E. coli; Lane3, Induced lysate of E.coli; Lane4, Purified GST-LdGDI. Similarly, cells transformed with mutant plasmid were used to purify the GST-LdGDI:R239A fusion protein.
Supplementary Figure 2.
Un-cropped images showing the localization of LdGDI:WT and its mutant in Leishmania. Full length blot showing the levels of overexpression of LdGDI:WT and its mutant as GFP fusion proteins in Leishmania.
Supplementary Figure 3.
Full length blot showing the extraction of LdRab5 from the endosome by LdGDI. Endosome were treated with LdGDI:WT or mutant in the presence of GDP. Treated endosomes were centrifuged; pellets (P) and supernatant (S) were analyzed for the presence of LdRab5 by western blots using anti-LdRab5 antibody.
Supplementary Figure 4.
Full length blot showing the role of LdGDI in the secretory pathway in Leishmania. To determine the role of LdGDI in the secretory pathway in Leishmania, we determined the levels of cell-associated and secreted gp63 by respective L. donovani promastigotes by western blot analysis using specific antibodies.
